AViTA Corporation (4735) Fair Value & Analysis
Healthcare · TW · Market cap 1.2B TWD
Fair value as of: Jul 21, 2026
From 14 valuation models · updated 20 days ago
Share price +10.5% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range (23.93 TWD to 43.72 TWD) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range 27.20 TWD – 86.19 TWD · fair‑value band 23.93 TWD – 43.72 TWD · the 34.15 TWD price screens below the 34.18 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
AViTA Corporation (4735) currently trades at 34.15 TWD, while our model-based Fair Value estimate is 34.18 TWD, implying the stock looks roughly 0.1% fairly valued today. The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, AViTA Corporation generated revenue of 953M TWD at a net margin of 13.5%. Revenue grew 8.2% year over year. It earns a return on equity of 12.6%. The balance sheet holds a net cash position of 378M TWD. Fundamentals as of Jul 21, 2026
Our scenario range runs from 23.93 TWD (bear case) to 43.72 TWD (bull case); at 34.15 TWD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 10% below its 52-week high and 18% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -22% fair-value upside, at 0%, 4735 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Multiples (41.14 TWD) versus Earnings-Based (16.79 TWD). Highest evidence: Residual Income (76).
Notify me when 4735 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 47 · Market factors (momentum, volatility) 61
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products. Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and …
Full company description
AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products. Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and electronic lice comb. AViTA Corporation was founded in 1996 and is headquartered in New Taipei City, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
AViTA Corporation reported revenue of 936M TWD in FY2025 versus 2.3B TWD in FY2021, a compound −20.3%/yr. Reported net income was 93.2M TWD in FY2025, compounding −26.3%/yr from FY2021.
Watch 4735: get an alert when its fair value changes →
Peer Group
Medical Devices · 352 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Devices median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $100.68 | $74.79 | -26% |
| Stryker Corporation SYK | $316.44 | $186.28 | -41% |
| Medtronic plc MDT | $83.56 | $65.57 | -22% |
| Boston Scientific Corporation BSX | $43.04 | $38.44 | -11% |
| Edwards Lifesciences Corporation EW | $85.73 | $41.02 | -52% |
| Siemens Healthineers AG SHL | €34.59 | €33.87 | -2% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥149.43 | ¥147.63 | -1% |
| Shanghai United Imaging Healthcare Co 688271 | ¥109.00 | ¥43.60 | -60% |
| Demant A/S DEMANT | kr 276.60 | kr 161.17 | -42% |
| Getinge AB GETIB | kr 206.80 | kr 192.14 | -7% |
Compare AViTA Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is AViTA Corporation (4735) overvalued or undervalued?
What is the fair value of 4735?
What is the quality score of 4735?
What is the revenue of AViTA Corporation (4735)?
What is the net profit margin of 4735?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track AViTA Corporation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.